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Treslin/Ticrr is required for the initiation of DNA replication and binds to
MTBP (Mdm2 Binding Protein). Here, we show that in Xenopus egg extract,
MTBP forms an elongated tetramer with Treslin containing two molecules
of each protein. Immunodepletion and add-back experiments show that
Treslin–MTBP is rate limiting for replication initiation. It is recruited onto
chromatin before S phase starts and recruitment continues during S phase.
We show that DDK activity both increases and strengthens the interaction
of Treslin–MTBP with licensed chromatin. We also show that DDK activity
cooperates with CDK activity to drive the interaction of Treslin–MTBP
with TopBP1 which is a regulated crucial step in pre-initiation complex
formation. These results suggest how DDK works together with CDKs to
regulate Treslin–MTBP and plays a crucial in selecting which origins will
undergo initiation.1. Introduction
The initiation of eukaryotic DNA replication occurs at replication origins that
have been licensed by being loaded with double hexamers of MCM2–7 pro-
teins. The combined action of two kinases, DDK and S-CDK, then triggers
the recruitment of Cdc45 and the GINS complex onto these MCM2-7 double
hexamers to form the replicative CMG (Cdc45–MCM–GINS) helicase. In vitro
experiments in Xenopus egg extract have shown that DDK activity is required
before S-CDK activity [1,2]. DDK-mediated hyperphosphorylation of Mcm4
but not Mcm2 correlates with replication initiation in both Xenopus egg extract
and human cells [3,4]. In Saccharomyces cerevisiae, DDK phosphorylation of
MCM2–7 promotes the recruitment of Sld3 and Cdc45 to origins, and then
S-CDK phosphorylation of Sld3 and Sld2 allows the recruitment of Dbp11,
Sld2, Sld3, GINS and Pol ε [5–8]. DDK-dependent MCM phosphorylation is
reversed by protein phosphatase 1 targeted to chromatin by Rif1 in Xenopus
egg extract and in both S. cerevisiae and human cells [3,4,9,10].
Sld7 was identified in S. cerevisiae as a gene that is synthetically lethal with
Dpb11 [11,12]. Despite Sld7 not being absolutely required for DNA replication,
it physically interacts with Sld3 and is required for the proper function of Sld3
at initiation [8,12,13]. Sld7 mutants have reduced total levels of Sld3 and
delayed dissociation of Sld3 from GINS at replication initiation [12]. The crystal
structures obtained from Sld3 and Sld7 domains suggest a model of interaction
between these proteins in which two molecules of Sld7 interact with each
other in an antiparallel manner through their C-terminal domains [14]. The
N-terminal domain of Sld7 interacts with the N-terminal domain of Sld3 to
form a tetramer in which the two molecules of Sld3 are connected by the two
molecules of Sld7 [14]. This conformation could allow the correct positioning
of Sld3 onto the double hexamer of MCM2–7 in order to promote bidirectional








































MTBP was identified in a yeast two-hybrid screen as an
interacting partner of MDM2, the E3 ubiquitin ligase that
targets p53 for destruction [15]. In human cells, knockdown
of MTBP blocks cell growth and induces a G1 arrest
[15,16]. It is frequently found overexpressed in cancer
[17,18]. In human cells, MTBP has been identified as an inter-
acting partner of Treslin, the metazoan homologue of Sld3,
throughout the cell cycle [19]. An MTBP-interacting domain
has been identified on Treslin, upstream of the Cdc45-inter-
acting domain [19]. Treslin lacking the MTBP-interacting
domain is unable to rescue the DNA replication phenotype
of Treslin-depleted cells, indicating that the Treslin–MTBP
interaction is essential for replication [19]. MTBP siRNA
causes the impairment of CMG assembly and the lengthening
of S phase, suggesting a direct role in the initiation of DNA
replication [19].
Treslin interacts with TopBP1, the metazoan homologue
of Dpb11. CDK-dependent phosphorylation of the well-
conserved S1001 of Treslin mediates its interaction with the
phospho-binding BRCT domains of TopBP1 [19,20]. Mutation
of this residue, but not of the adjacent well-conserved CDK
consensus-site T969, significantly reduced the interaction of
Treslin with TopBP1 and cells harbouring a non-phosphoryla-
tablemutation of S1001were deficient in DNA replication [20].
The formation of a tripartite Treslin–MTBP–TopBP1 complex
in human cells is curtailed when Treslin’s conserved phospho-
sites are mutated [19]. CDK phosphorylation of Treslin is
therefore required both for the interaction of Treslin–MTBP
with TopBP1 and to support DNA replication in human
cells. Consistent with this, cells with a phosphomimetic
Treslin mutant display faster replication kinetics and a shorter
S phase [21]. In addition to Treslin–MTBP, RecQ4, the higher
eukaryotic homologue of yeast Sld2, is a potential CDK
substrate. Following phosphorylation of RecQ4, it associates
with licensed chromatin, together with Treslin–MTBP, to
form the pre-initiation complex (pre-IC) [22].
Here, we further characterize the role of MTBP in DNA
replication using the Xenopus egg extract cell-free system.
Our work complements and extends a recent report describ-
ing Xenopus MTBP [23]. We show that MTBP and Treslin
form a tetrameric complex that is required for the initiation
of DNA replication, similar to Sld3/Sld7 in yeast. However,
in this system, the regulation of MTBP binding onto chroma-
tin appears substantially different from Sld7 in yeast. We find
that DDK activity is required to both increase and strengthen
the interaction of Treslin–MTBP with chromatin and to med-
iate its association with TopBP1. Our data suggest a key role
for DDK activity in coordinating the interaction of Treslin–
MTBP with licensed replication origins and TopBP1, thereby
determining which origins are selected to undergo replication
initiation.2. Results
2.1. Characterization of MTBP and Treslin antibodies
In human cells, MTBP has been identified as an interacting
partner of Treslin involved in the regulation of the initiation
of DNA replication [19]. To identify how MTBP is involved
in DNA replication, we studied its role and regulation in
Xenopus egg extracts which support complete genome dupli-
cation in vitro [24]. We raised antibodies against the C0 and N0termini of Xenopus MTBP, which we denote as MTBP-1 and
MTBP-2, respectively. We also used a commercial antibody
raised against a conserved central region of the human protein,
which we denote by MTBP-S. The antibodies were used
to immunoblot whole Xenopus egg extract, replicating
chromatin and immunoprecipitates (electronic supplementary
material, figure S1a). While all the antibodies detected mul-
tiple bands in whole extract, they each recognized the same
single band on replicating chromatin of the expected molecu-
lar weight for MTBP. Importantly, they each also specifically
immunoprecipitated the same band. We also raised two
antibodies against Xenopus Treslin (Treslin-1 and Treslin-2),
which showed a similar specificity (electronic supplementary
material, figure S1b), and an antibody against Xenopus
TopBP1, which recognized only a single band of the expected
molecular weight in both whole egg extract and on isolated
chromatin (electronic supplementary material, figure S1c).
To confirm the identity of the major band identified by the
MTBP and Treslin antibodies, we performed mass spec-
trometry of the immunoprecipitates, which confirmed that
MTBP and Treslin were the major components of these
samples (electronic supplementary material, figure S2).
2.2. A Treslin–MTBP complex in Xenopus egg extract
To identify a possible Treslin–MTBP complex, we immuno-
precipitated Treslin and MTBP from aliquots of Xenopus egg
extract in either metaphase or interphase (figure 1a). Immuno-
blotting showed that MTBP antibodies co-precipitated Treslin
and Treslin antibodies co-precipitated MTBP. These results
indicate that in Xenopus egg extract, MTBP and Treslin form
a complex throughout the cell cycle. This is consistent with
previous reports in Xenopus egg extracts [23] and human
cells [19], and resembles the interaction between Sld3 and
Sld7 in yeast [12,13].
We next set out to determine the molecular weight of the
Treslin–MTBP complex. Elongated proteins appear larger
than spherical proteins of the same molecular weight when
analysed by size exclusion chromatography, but appear
smaller when analysed by sucrose gradient centrifugation.
However, by combining data from both separation tech-
niques (Stoke’s radius and sedimentation coefficient) and
using the Siegel & Monty equation [25], the native molecular
weight of a protein or protein complex can be determined
in a manner that is unaffected by its shape. We precipitated
proteins from a clarified supernatant of whole egg extract
using polyethylene glycol (PEG) (figure 2), selected the
protein fraction containing MTBP and Treslin, then analysed
it by size exclusion chromatography and sucrose gradient
centrifugation. MTBP and Treslin showed similar elution
profiles in size exclusion chromatography and sucrose gradi-
ent centrifugation, suggesting that in egg extract, they form a
single multimeric species. This complex has a Stoke’s radius
of 116 Å (figure 1b) and a sedimentation coefficient of 12.8 S
(figure 1c). Applying the Siegel and Monty equation gives a
molecular weight for the Treslin–MTBP complex of
626 kDa. This is close to (± less than 1%) the expected mol-
ecular weight of a 632 kDa tetramer composed of two
molecules of MTBP (96 kDa) and two molecules of Treslin
(220 kDa). The Treslin–MTBP complex appears larger on gel
filtration than thyroglobulin tetramer (1338 kDa, 107 Å) and
smaller on sucrose gradients than β-amylase (200 kDa, 54 Å,






radius (Å)  
































Figure 1. Treslin–MTBP complex in Xenopus egg extract. (a) Immunoprecipitation of MTBP and Treslin from metaphase (M) or interphase (I) extract using affinity
purified MTBP-1 and Treslin-1 antibodies, immunoblotted for MTBP and Treslin. (b) Gel filtration of 3% PEG-precipitated proteins from Xenopus egg extract immu-
noblotted for MTBP and Treslin. The position and calculated Stoke’s radius of the Treslin–MTBP peak are indicated. (c) 5–40% sucrose gradient centrifugation of 3%








































Quantitative immunoblotting that compares the signal of
MTBP in extract with the signal from known quantities of the
MTBP-2-antigen suggested that the concentration of MTBP in
undiluted egg extract is approximately 0.2 µg ml−1 or approxi-
mately 2 nM (electronic supplementary material, figure S3).
The concentration of the proposed Treslin–MTBP tetramer
is, therefore, approximately 1 nM.Xenopus egg extract can effi-
ciently replicate approximately 30 ng DNA µl−1 of extract [26]
with active replication origins spaced approximately
10 kb apart [27]. At 30 ng DNA µl−1, the concentration of
active origins is, therefore, approximately 4 nM, suggesting
that Treslin–MTBP is involved in replication initiation at
rate-limiting levels.
2.3. Purification of Treslin–MTBP complex
To investigate the composition of the Treslin–MTBP complex,
we carried out a partial chromatographic purification
(figure 2a). First, we precipitated proteins from a clarified
supernatant of whole egg extract using PEG (figure 2b(i)),
then used cation and anion exchange chromatography to
further enrich MTBP and Treslin (figure 2b(ii,iii)). We carried
out a final ammonium sulfate precipitation in order to con-
centrate the protein fractions. During the purification, we
achieved a 1200-fold reduction of total protein as estimated
by UV absorbance at 280 nm with a yield of MTBP and Tre-
slin of 48% and 49%, respectively (figure 2c). Combining data
for the yield with protein concentration measurements
suggests that MTBP and Treslin were both enriched greater
than 600-fold (figure 2c).
Immunoprecipitation of the enrichedmaterial withMTBP-
1 antibodies co-precipitated Treslin, though less efficiently
than in whole extract, suggesting that the complex was
only partially maintained throughout the chromatographicprocedures (figure 2d ); consistent with this a fraction of
MTBP separate from Treslin is found on cation exchange
chromatography (figure 2b(iii)). Total protein staining of the
immunoprecipitates showed major bands at the expected
position of MTBP and Treslin and as expected, the higher mol-
ecularweight Treslin band is themore intense (figure 2e). Mass
spectrometry confirmed thatMTBPand Treslinwere themajor
protein components of the immunoprecipitate (electronic sup-
plementary material, figure S4). We were unsuccessful in
reducing the number of bands in the immunoprecipitates by
increasing salt concentration during the wash steps, because
this strongly reduced the co-precipitation of Treslin with
MTBP antibodies. Taken together, our results strongly suggest
that MTBP and Treslin form a 2 : 2 heterodimer, though the
partial purification falls short of providing definitive evidence
for this.
Mass spectrometry of the MTBP immunoprecipitate
identified other proteins, including components of the
origin recognition complex (ORC), Werner’s helicase
(WRN) and Topoisomerase IIα. To test whether any of these
interactions were specific, we immunoblotted MTBP-1
immunoprecipitates with antibodies to these proteins. Orc1,
Orc2 andWRNwere detected in MTBP-1 immunoprecipitates
(figure 2f ). We therefore conclude that although MTBP
and Treslin exist primarily as a hetero-tetramer in egg
extract, they can also associate with other proteins to a
limited extent.
The Treslin–MTBP hetero-tetramer is present in interphase
egg extracts (figure 1). Following nuclear formation, these
extracts support one complete round of DNA replication. To
determine whether the Treslin–MTBP complex is present on
chromatin during S phase, we performed a chromatin immu-
noprecipitation (ChIP) from replicating nuclei isolated from












0–3% PEG 14 94.9 13.289 99.5 13.93
SP 20.41 60.75 173.59 64.8 185.16
ANX 4.4 48 603.48 49 616.06















































































































(i) PEG precipitation 
Figure 2. Treslin–MTBP complex purification. (a) Flow chart of the purification process. (b) Immunoblots of MTBP and Treslin present in (i) PEG, (ii) SP and (iii) ANX
fractions. (c) Table of purification achieved for MTBP and Treslin. (d,e) Purified material was immunoprecipitated using MTBP-1 affinity purified antibody. Samples
were immunoblotted for MTBP and Treslin (d ) and run on a NuPage gel and stained with SYPRO Ruby (e). ( f ) MTBP immunoprecipitate from whole extract was run
on NuPage gels and immunoblotted for the indicated proteins. (g) Sperm nuclei were incubated in interphase extract for 30 min; chromatin was isolated, digested








































with nuclease and performed MTBP immunoprecipitation.
Treslin was also co-precipitated with MTBP, at levels compar-
able to the total amount loaded onto chromatin, suggesting
that the two proteins remain associated with one another
when bound to DNA. This also suggests that, consistent
with the chromatography data, there is no significant excess
of Treslin over MTBP in the extract. MTBP also co-precipitated
Cdc45 and Sld5 on chromatin (figure 2g); these proteins are
members of the CMG helicase, consistent with the idea that
the Treslin–MTBP complex is involved in assembling the
CMG complex.2.4. Regulation of MTBP recruitment onto chromatin
As a first step to characterising the function of MTBP in DNA
replication, we analysed the chromatin recruitment of MTBP
and Treslin at various times after adding sperm nuclei to
interphase extract. MTBP and Treslin were recruited onto
chromatin at 15 min, during the licensing phase and before
replication initiation, when Cdc45 and PCNA were not yet
present on chromatin (figure 3a). The MTBP and Treslin
signal peaked at 30 min during S phase, when CMG proteins





































































































































Figure 3. MTBP loading onto chromatin in metaphase and interphase extract. (a,b) Sperm nuclei were incubated in interphase (a) or metaphase (b) extract for the
indicated times; chromatin was isolated, run on NuPage gels and immunoblotted for the indicated proteins. The lower portion of the gel was stained with SYPRO
Ruby to detect histones. Ex, extract control. (c–f ) Sperm nuclei were incubated in interphase extract for the indicated times in the presence of either: (c) geminin,
(d ) p27KIP1, (e) PHA-767491 or ( f ) wheat germ agglutinin (WGA); chromatin was isolated, run on NuPage gels and immunoblotted for the indicated proteins. The
lower portion of the gel was stained with SYPRO Ruby to detect histones. Ex, extract control; ctrl, control chromatin incubated for 30 min in interphase extract
without drug treatment. (g,h) Sperm nuclei were incubated in interphase extract for 60 min in the presence of either geminin, p27KIP1, PHA or a combination of two
of these; chromatin was isolated at the indicated salt concentration, run on a NuPage SDS–PAGE gel and immunoblotted for Treslin. The lower portion of the gel








































Mcm10 and AND1/Ctf4) and DNA synthesis proteins (RPA,
PCNA and the three replicative polymerases α, β and ε) were
present on chromatin, and decreased during the later stages
of S phase consistent with these (figure 3a; electronic sup-
plementary material, figure S5). By contrast, when sperm
chromatin was incubated in metaphase-arrested extract,
neither MTBP nor Treslin were recruited to the chromatin
(figure 3b). These results indicate that MTBP and Treslin bind
chromatin before S phase starts and peak during S phase,
consistent with them being involved in replication initiation.
We next carried out chromatin isolation from interphase
extract supplemented with geminin to block replication licen-
sing and prevent the MCM2–7 complex from loading onto
chromatin [28–30]. Figure 3c and electronic supplementary
material, figure S6a show that whereas geminin significantlyinhibited MTBP and Treslin recruitment onto chromatin,
which peaked at 15 min and then declined, all CMG helicase
and all other pre-IC proteins are unable to associate with chro-
matin when licensing is inhibited. A similar decrease in MTBP
and Treslin association with chromatin was observed in extract
treated with RL5a, a small molecule which inhibits the ability
of ORC to bind productively with DNA and which thereby
inhibits origin licensing [31] (electronic supplementary
material, figure S6).
To verify whether MTBP requires S phase kinase activity
to load onto chromatin, we inhibited the DDK and CDK
activities that are required for the initiation of DNA replica-
tion in Xenopus egg extract [1,2,32–34]. Treslin is a substrate
for S phase CDKs, and its phosphorylation is required for it








































[20,35–39]. DDK is recruited to MCM2–7 at licensed origins
where it phosphorylates Mcm2 and Mcm4 [1–4].
Figure 3d and electronic supplementary material, figure
S6b show that in extract treated with the CDK inhibitor
p27KIP1, the Cdc45 and GINS (Psf2 and Sld5 proteins) com-
ponents of CMG, pre-IC protein TopBP1 and the proteins
required for DNA synthesis do not associate with chromatin,
but MTBP and Treslin were loaded onto chromatin to higher
levels compared to the control, consistent with a previous
report that inhibition of CDKs causes a hyper-loading of
Treslin in Xenopus egg extracts [38]. This indicates that neither
MTBP nor Treslin need S phase CDK activity to load onto
chromatin, and that CDK activity actually reduces their
loading. RecQ4 was also loaded onto chromatin at near
normal levels when CDK activity was inhibited (electronic
supplementary material, figure S6).
When PHA-767491 was added toXenopus extract to inhibit
DDK activity [3,4,40], MTBP and Treslin peaked on chromatin
at 15 min at levels comparable to the control, but then declined,
whereas other than theMCMproteins, all other components of
CMG, all other pre-IC and the proteins required for DNA
synthesis did not associate (figure 3e; electronic supplementary
material, figure S6c). When we used WGA to inhibit nuclear
pore function [41]—thereby reducing the effective concen-
tration of replication factors around DNA—Treslin–MTBP
recruitment stayed at an approximately constant level compar-
able to the peak seen in control extract (figure 3f ). This could be
explained by the opposing effects of reducing the concen-
trations of Treslin–MTBP and DDK concentrations around
DNA which would tend to reduce Treslin–MTBP loading,
while at the same time reducing CDK activity around DNA
which would tend to increase Treslin–MTBP loading.
The reduced chromatin association of Treslin–MTBP in
extracts treated with either geminin or RL5a to inhibit
licensing and PHA-767491 to inhibit DDK activity is in
stark contrast to the hyperloading seen when CDK activity
is inhibited by p27KIP1 (figure 3; electronic supplementary
material, figures S5 and S6). This removal of Treslin–MTBP
from chromatin following the peak association at 15 min
and hyperloading is consistent with nuclear formation and
the concomitant increase of local CDK activity. To determine
the combined effect of inhibiting both licensing and either
CDK or DDK activity, we isolated chromatin from egg extract,
in increasing concentrations of salt, that had been treated
either with p27KIP1, geminin or PHA-767491 alone or in com-
bination; chromatin isolated in increasing concentrations of
KCl allows discrimination between different states of protein
chromatin association [42]. Figure 3g shows that irrespective
of whether replication licensing has occurred, inhibition of
CDK both increases and stabilizes the association of Tre-
slin–MTBP with chromatin. Figure 3h shows that the initial
binding of Treslin to chromatin is largely unaffected by licen-
sing or DDK inhibition, but is still stimulated by CDK
inhibition when DDK is inhibited. Taken together, these
results suggest that CDKs play a role in destabilizing the
interaction between Treslin–MTBP and chromatin that is
largely independent of other replication activities.
2.5. Involvement of MTBP in DNA replication
To verify the involvement of MTBP in DNA replication, we
immunodepleted MTBP from Xenopus egg extract using the
MTBP-1 and MTBP-2 antibodies. The residual MTBP andTreslin in the depleted extracts was approximately 5% (elec-
tronic supplementary material, figure S7a). Extracts
depleted with MTBP-1 or MTBP-2 antibodies showed a
strongly reduced ability to support DNA replication
(figure 4a). To verify that both the MTBP-1 and MTBP-2 anti-
bodies depleted the same factor required for replication, we
performed complementation assays, where equal volumes
of depleted extract were mixed and then subjected to a repli-
cation assay. Mixtures of mock-depleted extract and MTBP-1
or MTBP-2 depleted extracts supported replication, while
mixtures of MTBP-1 and MTBP-2 depleted extracts did not
(electronic supplementary material, figure S7b). This indi-
cates that the MTBP-1 and MTBP-2 antibodies deplete the
same essential factors required for DNA replication.
Even though in MTBP-depleted extracts, DNA replication
was significantly reduced the depleted extracts could still
efficiently support complementary strand synthesis on
single-stranded M13 plasmid DNA (electronic supplemen-
tary material, figure S7c) and nuclear assembly was not
impaired (electronic supplementary material, figure S7d).
To determine the amount of Treslin–MTBP complex required
for DNA replication, we performed serial dilutions of normal
extract into MTBP-depleted extracts and tested the amount of
DNA synthesis (figure 4b). This showed that 5% by volume of
undepleted extract could rescue replication to an efficiency of
approximately 50% in the depleted extracts. This is equal to
an MTBP concentration of approximately 0.1 nM and a Tre-
slin–MTBP tetramer concentration of approximately
0.05 nM. Given the significantly longer S phase observed in
immunodepleted extracts, this is consistent with the hypoth-
esis that MTBP is present at limiting levels for replication
initiation.
We next carried out a rescue experiment adding an ali-
quot of partially purified Treslin–MTBP (figure 2) to extract
depleted with MTBP antibodies. Ammonium sulfate precipi-
tation was used to concentrate the Treslin–MTBP sufficiently
to allow assay, but residual ammonium sulfate in the sample
was somewhat inhibitory to DNA replication. As positive
control for rescue, we used the maximum rescue achieved
by Treslin–MTBP concentrated after precipitation with PEG
(directly from extract; figure 4c). The fraction containing the
600-fold enriched Treslin–MTBP complex rescued replication
to 60% compared to the positive control. This highly efficient
rescue strongly suggests that Treslin–MTBP is the replication
factor missing in the depleted extracts.
We next asked whether MTBP alone is sufficient to rescue
the replication phenotype of the MTBP-depleted extract, or
whether the Treslin–MTBP complex is required. During
anion exchange chromatography, approximately 20% MTBP
elutes before the Treslin peak, suggesting that MTBP is in
slight excess in egg extract (figure 2). We compared the abil-
ity of fractions containing MTBP only or the Treslin–MTBP
complex (figure 4d; electronic supplementary material,
figure S7e) to rescue DNA replication in MTBP-depleted
extract. While fractions containing Treslin–MTBP could
rescue DNA replication to approximately 30% of the positive
control, comparable amounts of MTBP in the MTBP-only
fraction were not able to rescue replication at all. These results
suggest that MTBP alone is not sufficient to rescue the repli-
cation phenotype of the MTBP-depleted extract and that
Treslin is an essential factor for replication.
To verify which step of DNA replication was impaired
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Figure 4. Immunodepletion of MTBP from Xenopus egg extract. (a) DNA replication was assayed in the indicated depleted extracts (average of three independent
experiments, error bars represent standard error). (b) Undepleted extract was titrated into MTBP-1-depleted extract and DNA synthesis was assayed after 3 h. The
average of three independent experiments; error bars represent standard error. Sperm nuclei were added to a final concentration of 3 ng µl−1. (c) MTBP-1-depleted
extract was incubated with H2O, 3% PEG or ammonium sulfate concentrated partially purified MTBP–Treslin complex diluted in H2O (300 pM). Replication was
assayed at the indicated times. Average of three independent experiments; error bars represent standard error. (d ) MTBP or Treslin–MTBP was delivered to
MTBP-1-depleted extract at either 40 or 80 pM. Sperm chromatin was added and replication was assayed after 3 h, expressed as a percentage of the replication
achieved in depleted extract supplemented with an excess of the 3% PEG fraction. Average of three independent experiments; error bars represent standard error.
(e) Mock or MTBP-1-depleted extract were supplemented plus or minus sperm chromatin; after 90 min chromatin was isolated, run on a NuPage gel and immuno-
blotted for the indicated proteins. ( f ) Mock or Treslin-1-depleted extract were supplemented with sperm chromatin; chromatin was isolated at the indicated times,








































isolation from MTBP-depleted, Treslin-depleted or mock-
depleted extracts 90 min after the addition of sperm DNA
to the extracts. In the MTBP- and Treslin-depleted extract,
TopBP1 was recruited to chromatin, but the recruitment
of RecQ4, Cdc45 and PCNA was strongly reduced
(figure 4e,f ). Since maximal loading of Treslin–MTBP requires
both licensing and DDK activity and in addition to these
TopBP1 loading requires CDK activity, we next determinedthe dynamic association of TopBP1 across the replication
cycle in the absence of Treslin–MTBP. Figure 5a shows that
TopBP1 chromatin association followed that of Treslin–
MTBP, with a peak of binding during S phase which then
declines as S phase proceeds. In extract depleted of Treslin–
MTBP, the association of TopBP1 with chromatin was
reduced but did not decline at later times. When either licen-
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Figure 5. TopBP1 chromatin association in the absence of MTBP. (a) Mock or MTBP-1-depleted extract was incubated with sperm chromatin for the indicated times,
chromatin was isolated, run on a NuPage gel and immunoblotted for the indicated proteins. The lower portion of the gel stained with SYPRO Ruby to detect
histones. (b,c) Mock or MTBP-1-depleted extract were supplemented with sperm chromatin and either ± (b) geminin or (c) p27KIP1; after 60 min chromatin








































geminin or p27KIP1, the association of TopBP1 during peak S
phase in the absence of Treslin–MTBP was maintained
though at a reduced level (figure 5b,c). In combination,
these results suggest that although TopBP1 can associate
with licensed chromatin in the presence of CDK activity,
maximal binding during a normal S phase requires Treslin–
MTBP. This extends previous reports of Treslin and MTBP
depletion [23,38], and indicates that MTBP depletion impairs
the assembly of the pre-IC required for the formation of the
CMG helicase on chromatin.
To determine whether the Treslin–MTBP complex loaded
onto DNA in the absence of CDK or DDK activity is
functional, we carried out chromatin transfer experiments
(figure 6a). Sperm chromatin was incubated for 60 min in
extract supplemented with p27KIP1 or PHA-767491 to inhibit
CDK or DDK activities; the chromatin was then isolated and
transferred to MTBP-depleted extract to determine if the pre-
viously loaded MTBP and Treslin could support replication
initiation. As control, the same DNA templates were added
to extract mock-depleted with non-immune IgG. Chromatin
from extracts treated with PHA-767491 and p27KIP1 were
able to replicate efficiently in MTBP-depleted extract, indicat-
ing that the Treslin–MTBP complex loaded onto chromatin in
these conditions is potentially functional (figure 6b).To verify whether the interaction between Treslin–MTBP
and MCM2-7 is strengthened by DDK activity, as occurs in
yeast [8], we treated interphase extract with p27KIP1 to block
replication initiation and compared the amount of MCM co-
precipitating with Treslin–MTBP plus or minus PHA-767491.
Figure 6c shows that the amount of Mcm4 co-precipitating
with Treslin–MTBP was lower when DDK activity was inhib-
ited. Significantly, the residual Mcm4 co-precipitating in the
presence of PHA-767491 was hyperphosphorylated compared
to bulk chromatin, consistent with the idea that Treslin–MTBP
binds more strongly to MCM2-7 that has been phosphorylated
by DDK. Consistent with the ability of Treslin–MTBP and
RecQ4 but not TopBP1 to associate with chromatin when
CDKactivity is inhibited, chromatin isolated fromp27KIP1-trea-
ted extract could replicate efficiently in Treslin–MTBP and
RecQ4 but not TopBP1-depleted extracts (figure 6d ).
In order to determine whether the low quantity of
Treslin–MTBP recruited to chromatin in the absence of licen-
sing was functional, we isolated chromatin from extracts
treated with geminin, which contained approximately 20%
of control levels of Treslin–MTBP, and assayed its ability to
replicate in MTBP-depleted extract. Figure 6e shows that the
chromatin from geminin-treated extract replicated to less






























































































































Figure 6. Treslin–MTBP complex regulation by replicative kinases. (a) Schematic of nuclear transfer experiments. (b) Sperm nuclei were incubated for 60 min in
extract supplemented with p27KIP1 or PHA-767491; chromatin was isolated and transferred to extract immunodepleted with MTBP-1 antibodies or non-immune IgG;
the extent of DNA synthesis after 180 min was determined. Average of three independent experiments; error bars represent standard error. (c) MTBP was immu-
noprecipitated from chromatin incubated in extract containing p27KIP1, in the presence or absence of PHA-767491 and samples were immunoblotted for the
indicated proteins. (d ) Sperm nuclei were incubated for 60 min in extract supplemented with p27KIP1; chromatin was isolated and transferred to extract immu-
nodepleted with either Treslin-1, TopBP1, RecQ4 antibodies or non-immune IgG; the total DNA synthesis at the indicated times was determined. (e) Sperm nuclei
were incubated for 60 min in extract supplemented with geminin; chromatin was isolated and transferred to extract immunodepleted with MTBP-1 antibodies or








































suggests that origin licensing and MCM2–7 loading are
required for Treslin–MTBP to be efficiently recruited to chro-
matin in a functional manner, but that the reduced amount of
Treslin–MTBP loaded onto DNA in the absence of MCM2-7 is
present in a potentially functional form.2.6. DDK activity regulates Treslin–MTBP–TopBP1
complex formation
We have shown that both licensing and DDK activity are
required both to increase and strengthen the association of
Treslin–MTBP with chromatin. This is consistent with the
hyperphosphorylation of Mcm4 that we have previously
shown correlates with DNA replication [3,4]. The hyperpho-
sphorylation of Mcm4 is reversed by Protein Phosphatase 1
(PP1) targeted to chromatin by Rif1. However, chromatin with
hyperphosphorylated Mcm4 isolated from egg extract treated
in the presence of I-2, an inhibitor of PP1, does not replicate
fully when transferred to an extract in which both DDK and
PP1 activity have been inhibited [3]. This suggests either that
dephosphorylation of Mcm4 occurs even in the presence of I-2
or that there is a second DDK substrate required for the efficient
initiation ofDNAreplication. In considering possible additional
DDK substrates, we noted that chromatin-associated Treslinmigrated slower in gels compared to the bandpresent in extract,
and that this slower migrationwas reducedwhen DDK activity
was inhibited (figure 6c), suggesting that Treslin itself maybe a
DDK substrate.
We, therefore, further characterized the change in Treslin
migration in the presence of DDK inhibition by PHA-767491.
We treated egg extract with inhibitors of either DDK or CDK
activity alone or in combination, isolated chromatin following
nuclear assembly during S phase and analysed Treslin mobi-
lity by immunoblotting. Figure 7a shows that upon inhibition
of either DDK or CDK activity alone Treslin migrates faster
than seen in control but to a different extent; in combination,
inhibition of both DDK and CDK activity, results in Treslin
migrating faster than in each of the treatments alone
suggesting that both DDK and CDK independently contrib-
ute to the changes in Treslin mobility and that Treslin is a
target of DDK activity.
Treslin–MTBP associates with chromatin-bound MCM2-7
and also forms a tripartite complexwith TopBP1, thereby coup-
ling replication licensing and pre-IC formation. We reasoned
that since Treslin–MTBP associates more strongly with DDK-
mediated hyperphosphorylated Mcm4 at licensed replication
origins, DDK activity may also be required in addition to CDK
activity to mediate Treslin–MTBP and TopBP1 interaction. We
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Figure 7. DDK and PP1 regulate CDK-mediated Treslin–MTBP and TopBP1 interaction. (a) Sperm nuclei were incubated in extract supplemented with either 100 nM
p27KIP1 or 50 µM PHA-767491 alone or in combination, as indicated, for 60 min; chromatin was isolated, run on a NuPage gel and immunoblotted for Treslin. (b–f )
Diluted and clarified egg extract was supplemented with cyclin A, p27KIP1, PHA-767491, TAK-931, Tautomycetin, either alone or in combination, as indicated and
incubated for 15 min. Samples were immunoprecipitated using either control IgG or anti-TopBP1-antibody-bound protein-G Dynabeads. Washed precipitates were
subjected to SDS–PAGE on a NuPage gel. The upper portion of the gel was immunoblotted for Treslin, MTBP and TopBP1 as indicated and the lower portion of the









































promote interaction between Treslin–MTBPand TopBP1. In the
absence of nuclear formation, CDK activity in egg extract is low;
upon nuclear formation and protein import, the local concen-
tration of CDK activity within nuclei increases at least 25-fold,
a level sufficient to induce replication initiation. In egg extract,
the CDK1 catalytic subunit is in approximately 50-fold excess
compared to its activating cyclin partners so addition of cyclin
stimulates CDK activity in vitro [34]. To mimic the nuclear
environment in which Treslin–MTBP–TopBP1 interaction
occurs, we titrated cyclin A into fivefold diluted and clarified
egg extract in the absence of DNA and assessed the formation
of the Treslin–MTBP–TopBP1 complex by determining the
recovery of Treslin in TopBP1 immunoprecipitates (figure 7b).
The Treslin–TopBP1 interaction was maximal upon addition
of 10 nM cyclin A into egg extract but declined thereafter as
cyclin A concentration is further increased, concentrations at
which the little Treslin that is seen to interact with TopBP1 is
increasingly retarded in mobility. Maximal Treslin–TopBP1interaction upon the addition of 10 nM cyclin A is consistent
with the level of Cdk2–cyclin A required to support maximal
DNA replication in whole egg extracts, above which the extract
enters a mitotic-like state [34].
We next determined the effect of the addition of inhibitors
of DDK to egg extract on cyclin A-stimulated Treslin–TopBP1
interaction. Figure 7c,d shows that the addition of the DDK
inhibitors PHA-767491 or TAK-931 reduced the interaction
of Treslin with TopBP1. TAK-931 (simurosertib) is a recently
identified thieno-pyrimidinone-based inhibitor of Cdc7 [43].
Electronic supplementary material, figure S8a–c shows that
compared to PHA-767491, TAK-931 is a more specific but
marginally less potent inhibitor of DNA replication and
DDK-mediated chromatin-associated Mcm4 phosphorylation
in egg extract. Like PHA-767491 (figure 7a), addition of TAK-
931 to extract enhances the mobility of Treslin on gels (elec-
tronic supplementary material, figure S8d), consistent with














































































Figure 8. PP1 reverses DDK-mediated inhibition of CDK-mediated Treslin–MTBP and TopBP1 complex formation. (a,b) Diluted and clarified egg extract was sup-
plemented with either 10 nM cyclin A, 100 nM p27KIP1, 10 µM PHA-767491, 10 µM TAK-931, 250 nM Tautomycetin, either alone or in combination, as indicated and
incubated for 15 min. Samples were immunoprecipitated using either control IgG or anti-TopBP1-antibody-bound protein-G Dynabeads. Washed precipitates were
subjected to SDS–PAGE on a NuPage gel. The upper portion of the gel was immunoblotted for Treslin, MTBP and TopBP1 as indicated and the lower portion of the
gel stained with Coomassie to visualize the heavy and light chains of IgG. (c) Extract immunodepleted with a control IgG or anti-Cdc7 (DDK) antibody was either
supplemented or not with 10 nM cyclin A, as indicated and incubated for 15 min. Samples were immunoprecipitated using either control IgG or anti-TopBP1-
antibody-bound protein-G Dynabeads. Washed precipitates were subjected to SDS–PAGE on a NuPage gel. The upper portion of the gel was immunoblotted








































Furthermore, figure 7c,d shows that both PHA-767491 and
TAK-931-mediated inhibition of Treslin–TopBP1 interaction
was partially reversed upon co-addition of the PP1 inhibitor
Tautomycetin into extract, consistent with the role of PP1 in
reversing DDK-mediated phosphorylation of Mcm4 [3,4].
Similar (though less strong) inhibition was obtained with a
third DDK inhibitor, XL413 (electronic supplementary
material, figure S9a). These results suggest that DDK activity
is required for the interaction of Treslin–MTBP and TopBP1
and that this is subject to regulation by PP1.
Whereas CDK activity in the absence of nuclear formation
is low in egg extract, DDK activity is detectable but reduced
[3,4]. To further address the role of DDK activity on the for-
mation of the Treslin–MTBP–TopBP1 complex, we next
determined the effect of combined inhibition of both DDK
and CDK activity on their interaction. Figure 7e,f shows that
cyclin A’s ability to stimulate formation of the Treslin–
MTBP–TopBP1 complex is curbed both by inhibiting CDK
activity with p27KIP1 and by inhibiting DDK activity with
either PHA-767491 or TAK-931. The inhibition of both
CDK and DDK activities reduced complex formation to the
greatest extent but no more so than with DDK inhibitor
alone. Similar though less strong inhibition was obtainedwith XL413 (electronic supplementary material, figure S9b).
This suggests both that the formation of the Treslin–MTBP–
TopBP1 complex is dynamic and that DDK activity is required
for the CDK-dependent formation of the complex.
The dynamic nature of the Treslin–MTBP–TopBP1 inter-
action is consistent with the role we identified for PP1 in
reversing DDK inhibition of complex formation (figure 7c,d).
Maximal interaction required both optimal CDK and DDK
activity. Figure 8a,b shows that addition of the PP1 inhibitor
Tautomycetin alone stimulated the interaction between
Treslin–MTBP and TopBP1, although not to the same extent
as the addition of cyclin A. Maximal complex formation was
seen when both DDK and CDK activity were stimulated by
the combined addition of both Tautomycetin and cyclin
A. Whereas addition of either PHA-767491 or TAK-931
reversed the stimulation seen upon addition of Tautomycetin,
the further addition of cyclin A could overcome this to some
extent. These results are consistent with the idea that DDK
activity is actually more important than CDK activity for the
formation of the Treslin–MTBP–TopBP1 complex. Complex
formation was more strongly reduced by DDK inhibition
than by CDK inhibition (figure 7e,f). Stimulation of DDK-








































complex formation in the absence of cyclin A, but only very
low levels of complex formation occurred when DDK activity
was inhibited in the presence of cyclin A. Similar though less
strong inhibition was obtained with XL413 (electronic sup-
plementary material, figure S9c). Taken together, these results
suggest that DDK activity is essential for the formation of the
Treslin–MTBP–TopBP1 complex, while optimal CDK activity
further strengthens the interactions.
To address directly the role of DDK activity in Treslin–
MTBP–TopBP1 complex formation, we next prepared extract
immunodepleted of Cdc7. Immunodepletion of at least 95%
of Cdc7 from the extract left MTBP levels similar to those in
control depleted extract (electronic supplementary material,
figure S10a). Consistent with the results presented above
using both PHA-767491 and TAK-931 to inhibit DDK activity,
removal of Cdc7 from egg extract reduced the interaction of
Treslin–MTBP with TopBP1 both in the presence and absence
of additional cyclin A (figure 8c; electronic supplementary
material, figure S10b). 1213. Discussion
In this study, we show that in Xenopus egg extracts, MTBP
and Treslin form an elongated complex that is recruited to
DNA before replication initiates. The Treslin–MTBP complex
can be recruited to DNA in a functional form in the absence
of replication licensing, DDK or CDK activity, but licensing
and DDK activity stabilizes the interaction between Treslin–
MTBP and chromatin-bound MCM2-7. We find that the
Treslin–MTBP complex is present in extract at a low concen-
tration expected to be rate limiting for replication initiation.
We also demonstrate an important and previously unrecog-
nized role for DDK activity in promoting the interaction
of Treslin–MTBP with TopBP1. Since DDK also has an
essential role in phosphorylating chromatin-bound MCM2-
7, this suggests that DDK plays a central role in directing
the recruitment of Treslin–MTBP and TopBP1 to licensed
replication origins, thereby selecting which origins will
subsequently initiate.
Treslin andMTBP co-immunoprecipitatewith each other in
both metaphase and interphase extract indicating that they
interact throughout the cell cycle, as previously reported in
human cells and Xenopus, and similar to Sld3 and Sld7 in bud-
ding yeast [13,19,23]. Using a combination of sucrose gradient
sedimentation and gel filtration, we show that the Treslin–
MTBP complex has a native molecular weight of 626 kDa,
close to (± less than or equal to1%) the value expected for a tet-
ramer composed of two molecules of MTBP (96 kDa) and two
molecules of Treslin (220 kDa), that is 632 kDa. The distinct
behaviours of Xenopus Treslin–MTBP on gel filtration and
sucrose gradients suggest that it forms a highly elongated com-
plex. This result is in linewith themodel proposed for Sld3 and
Sld7 in yeast—obtained from studies of the crystal structures of
domains of Sld3 and Sld7—which proposed that two mol-
ecules of Sld7 could bridge two molecules of Sld3, with one
loaded onto each of the hexamers of MCM2-7 loaded at an
origin to allow bidirectional initiation [14].
MTBP and Treslin also interact on chromatin during S
phase and at this time they also interact with Cdc45 and
the GINS complex, consistent with the idea that they function
during replication initiation. Immunodepletion of MTBP
from Xenopus egg extract co-depleted Treslin withimpairment of DNA replication due to the lack of CMG
assembly, supporting the idea that Treslin–MTBP is required
for CMG formation. The capacity to initiate replication could
be restored to MTBP-depleted extract by co-addition of a par-
tially purified Treslin–MTBP complex, but not by fractions
containing MTBP alone. This is consistent with a recent
report which shows that DNA replication in an MTBP-
depleted extract can be rescued with a combination of
recombinant Treslin and MTBP, but not either alone [23].
We found that MTBP was recruited onto chromatin during
licensing and peaked in S phase, similar to Treslin. The chroma-
tin recruitment of MTBP and Treslin occurred in the absence of
licensing, DDK, CDKor nuclear assembly (figure 9a(i)), but did
not occur in metaphase-arrested extract. Chromatin transfer
experiments showed that the Treslin–MTBP recruited onto
chromatin in the absence of licensing, DDK or CDK could effi-
ciently support replication in MTBP-depleted extract; this
suggests that Treslin–MTBP binds unlicensed chromatin in a
form that can be efficiently activated when other initiation
activities are supplied. These results differ from studies in
yeast, where the loading of Sld3 and Sld7 onto origins depends
on licensing and DDK activity [7]. However, we show that in
extract where licensing was abolished by addition of active
geminin or RL5a, the loading of MTBP and Treslin onto chro-
matin was strongly reduced compared to control, indicating
that the MTBP and Treslin loading that occurs before licensing
is relatively unstable (figure 9a(ii)). MCM2–7 is known to be
phosphorylated by DDK and this phosphorylation is required
for pre-IC formation [1–4,44]. We show here that consistent
with data in yeast [8] the physical interaction between Tre-
slin–MTBP and MCM2–7 was strengthened by DDK activity
(figure 9a(iii)). The Treslin–MTBP bound to chromatin in the
absence of either licensing or DDK and CDK activity can sup-
port DNA replication, suggesting that it is in a potentially
active configuration.
Whereas both licensing and DDK activity are required to
both increase and strengthen the interaction of Treslin–MTBP
with chromatin, CDK activity reduces this interaction
(figure 9b(i–iii)). Treslin is a CDK substrate and interacts with
TopBP1 through its BRCT motifs following CDK-mediated
phosphorylation of Treslin S1001 [20,38,45]. It is therefore
likely that CDK-dependent phosphorylation of Treslin reduces
its affinity forMCM2–7while increasing its affinity for TopBP1.
Therefore, as CDK activity rises during S phase, Treslin–MTBP
is likely to be recruited to replication origins as part of a
complex with TopBP1 (figure 9b(iv,v)) and that this is a precur-
sor to the formation of the pre-IC (figure 9b(vi)). We find that,
in addition to the known regulation of the Treslin–TopBP1
interaction by CDK, DDK activity also plays a major role
(figure 9b(v,vi)). The inhibition of DDK activity either by the
addition of PHA-767491, TAK-931 or XL413 or by depletion
of Cdc7 restricts the interaction between Treslin–MTBP and
TopBP1, even in the presence of an optimal concentration of
cyclin A to support complex formation, identifying the DDK
dependence of CDK-mediated complex formation. In addition,
we find that the DDK-mediated regulation of complex for-
mation is subject to reversal by PP1. By increasing and
decreasing DDK and CDK activity separately, we provide
data suggesting that DDK activity is essential for the formation
of the Treslin–MTBP–TopBP1 complex, while optimal CDK
activity further strengthens the interactions.
Given that Treslin–MTBP binds to chromatin prior to
nuclear assembly when DDK activity is detectable but reduced
P P
















































Figure 9. Model for the role of Treslin–MTBP, DDK and CDK in pre-IC formation. (a) Model of the interaction of Treslin–MTBP with replication origins. (i) Treslin–
MTBP can bind weakly to DNA. (ii) Stronger binding of Treslin–MTBP to licensed origins (DNA-bound MCM2–7 double hexamers). (iii) Strongest binding of
Treslin–MTBP to licensed origins where MCM2–7 has been phosphorylated by DDK. (b) Model for pre-IC formation. (i) Licensed origin (DNA-bound MCM2–7
double hexamers). (ii) DNA-bound MCM2–7 is phosphorylated by DDK. Phosphorylation is reversed by PP1 recruited to origins by Rif1. (iii) Treslin–MTBP is recruited
to DDK-phosphorylated MCM2–7. This interaction is opposed by CDK, probably due to CDK phosphorylation of Treslin. (iv) Soluble Treslin bound to MTBP can be
phosphorylated by both CDK and DDK. (v) Phosphorylated Treslin–MTBP binds to TopBP1. (vi) The Treslin–MTBP–TopBP1 complex is recruited to








































and before CDK activity rises to support replication initiation,
it may be that TopBP1 is initially directed to Treslin–MTBP
associated with licensed and DDK-phosphorylated origins,
forming a complex directly at the origin (figure 9b(i–iii)), but
that as CDK activity rises during S phase, the Treslin–MTBP–
TopBP1 complex plays a major role in driving formation of
the pre-IC (figure 9b(vi–vi)). This suggests that in addition to
ensuring Treslin–MTBP–TopBP1 complex formation, CDK
activity facilitates the removal of Treslin–MTBP from unli-
censed chromatin, thus ensuring redistribution of the
complex to only licensed and DDK-phosphorylated origins
to maximize the levels of origin firing. DDK activity thus coor-
dinates the coupling of replication licensing to pre-IC
formation and therefore, ultimately, CMG formation, by both
directing the correct chromatin binding of Treslin–MTBP and
mediating its interaction with TopBP1.
Studies in S. cerevisiae suggest that Sld3, Sld2, Dpb11
and Dbf4 are present at limiting concentrations [12,13,46].
Moreover, overexpression of these factors together with over-
expression of Sld7 and Cdc45 increased the efficiency of
origin firing, including the firing of normally dormant origins
[46]. In Xenopus embryos, it has been found that Treslin,TopBP1, Drf1 and RecQ4 are limiting for replication after
the mid-blastula transition and the levels of these factors
regulate the speed of cell division [47]. We quantified the
amount of MTBP in Xenopus egg extract and found that the
concentration of the Treslin–MTBP tetramer is approximately
1 nM. This is significantly lower than most other replication
proteins and is lower than the estimated 4 nM of replication
origins that can be efficiently replicated in Xenopus embryos
and egg extracts [26,27]. Consistent with this, we showed
that the replication rate in extract is highly sensitive to the
concentration of Treslin–MTBP. This is also consistent with
a previous report showing that the majority of Treslin
becomes chromatin-bound as embryos approach the mid-
blastula transition [47]. The low concentration of Treslin–
MTBP in embryos is therefore likely to be rate limiting for
replication initiation as embryos approach the mid-blastula
transition and DNA concentration approaches the maximum
capacity observed in egg extracts.
In yeast, Sld3 is required for replication initiation but is
not part of the replisome and is not required for replication
fork progression [48,49]. The chromatin binding of Xenopus








































from chromatin in the later part of S phase when some repli-
somes are still active. As an initiation activity, Treslin–MTBP,
possibly also associated with TopBP1, is therefore expected
to be released from origins as they initiate, potentially
being able to bind again to unfired origins to promote
their initiation. At the maximum physiological concentration
of DNA in Xenopus egg extract (close to the DNA concen-
tration at the mid-blastula transition), the concentration of
active origins is approximately 4 nM [26,27]. We estimate
approximately 1 nM of the Treslin–MTBP tetramer in egg
extract, meaning that each molecule would have to drive
the initiation of an average of four origins at this maximum
DNA concentration. This is consistent with previous work
on the kinetics of origin firing in Xenopus extract which
estimated that S phase is driven by approximately 3 cycles
of origin firing [50]. Furthermore, given the known role of
the inhibition of DDK activity in checkpoint signalling
following the interruption of the progression of DNA replica-
tion, the identification of DDK and PP1 as regulators of
Treslin–TopBP1 complex formation provides a novel point
at which DNA replication could be regulated following
checkpoint activation.
Not all licensed replication origins initiate in any given S
phase, with the majority remaining dormant but able to
initiate in the case of replication stresses [51–55]. In Xenopus
egg extracts, less than 10% of DNA-bound MCM2–7 initiate
in an undisturbed S phase [51,56,57], meaning that at mid-
blastula transition DNA concentrations, the concentration of
DNA-bound MCM2–7 is at least 50 nM. Given the data we
present here, it is highly likely that Treslin–MTBP plays a cru-
cial role in determining which of the licensed origins are
selected for initiation. In egg extract, there is high DDK
activity so that almost all MCM2–7 loaded onto DNA
become phosphorylated by DDKs [3,4]. The loading of the
limited amounts of Treslin–MTBP is the earliest known
event in the initiation process that selects the origins that
will go on to initiate, as the other limiting factors (TopBP1
and RecQ4) act after Treslin–MTBP has been loaded. The
correct selection of replication origins is important for main-
taining genome stability by regulating the distribution
of active replication forks in response to replication stresses
[52,54,55]. We therefore predict that over- or under-
expression of Treslin–MTBP causes defects in correct origin
selection, providing an explanation for why MTBP is
misregulated in certain cancers [18].
Our data show that DDK directs the initiation of DNA
replication at individual origins by two distinct means: (i)
priming potential replication origins for activation by phos-
phorylating MCM2–7 to promote Treslin–MTBP association
and therefore pre-IC assembly, and (ii) directing formation
of the Treslin–MTBP–TopBP1 complex that selects these
primed origins for activation. With PP1 able to reverse both
of these DDK-mediated activities, the local balance of
DDK : PP1 activity, together with that of CDK, must therefore
be coordinated to control origin activation. The potential role
of a phosphatase such as PP2A to reverse the CDK-mediated
phosphorylation of Treslin required for Treslin–MTBP–
TopBP1 complex formation remains to be determined. That
Treslin–MTBP–TopBP1 complex formation requires the inte-
gration of the two S phase kinases, CDK and DDK,
potentially allows CDK to act as the ‘global’ regulator of S
phase progression, while ‘local’ control of the initiation of
DNA replication is delegated to DDK activity.4. Methods
4.1. Contact for reagent and resource sharing
Requests for resources, reagents and further information
should be directed to andwill be fulfilled by the corresponding
author.
4.2. Experimental model and subject details
4.2.1. Xenopus laevis
Wild-type, sexually mature (at least 1 year old) female and
male South African clawed frogs (Xenopus laevis) born and
reared in the UK (University of Plymouth) were used in
this study for the production of unfertilized eggs (from
which extracts were prepared) and sperm, respectively.
Frogs were maintained at 19°C in particulate filtered,
dechlorinated water, at a density of less than or equal to 15
animals per 60 l tank, in a purpose built ‘aquacentre’ and
were maintained by professional staff at the University of
Dundee adhering to Home Office (UK Government) animal
husbandry guidelines; the animals have access to a Home
Office (UK Government) approved veterinary surgeon. The
frogs were fed a vegetable and fish-based diet (Aquatic
Diets 3, Mazuri Zoo Foods) 2–3 times per week, as required.
4.3. Experimental procedures
4.3.1. Recombinant antigens, antibodies and inhibitors
Polyclonal antibodies were raised in rabbit against the follow-
ing polypeptides: MTBP-2: 125 N-terminal amino acids of








purified using rProtein-A Sepharose fast flow beads (Cytiva
LifeSciences) or affinity purified using HiTrap NHS-Acti-
vated HP columns (Cytiva LifeSciences). For Treslin,
polyclonal antibodies were raised in two different rabbits
against the N-terminal 487 amino acids of Xenopus Treslin,
with an N-terminal 6-histidine tag. For TopBP1, polyclonal
antibodies were raised in sheep against the N-terminal 596
amino acids of Xenopus TopBP1, with an N-terminal 6-histi-
dine tag.
Commercial antibodies used in this study are: anti-histone
H3 FL-136 rabbit (Santa Cruz; sc-10809); anti-hMTBP (MTBP-
S: Sigma-Aldrich HPA025694); anti-hPCNA (PC10: Santa
Cruz; sc-56). Antibodies against Xenopus proteins: Cdc45
and Sld5 [58]; Mcm4 [59]; Orc1 [60]; Orc2 [61]. Anti-Xenopus
WRN rabbit polyclonal antibody was a gift from H. Yan (Fox
Chase Cancer Center, Philadelphia, USA) [62]. Anti-rabbit
IgG, anti-sheep IgG and anti-mouse–HRP-linked antibodies
were from New England Biolabs. Anti-rabbit IgG, anti-
sheep IgG and anti-mouse IgG–Dylight 800 or Dylight 680
linked antibodies were from ThermoFisher Scientific.
Recombinant gemininDEL was as described [63]. Recombi-








































HIS-tagged bovine ΔN-cyclin A (187–419) was purchased from
MRC PPU Reagents & Services (DU12276). PHA-767491 was
produced by Division of Signal Transduction Therapy, Univer-
sity of Dundee, TAK-931 was purchased from Insight Biotech
(HY-10088) and XL413 was purchased from Axon Medchem
(no. 2268). Triticum vulgaris WGA was purchased from
Sigma-Aldrich (L9640).
4.3.2. Xenopus egg extract methods
Metaphase-arrested X. laevis egg extract and demembranated
Xenopus sperm nuclei were prepared as described [24,64].
Female frogs were primed with 50 units of Folligon (Pregnant
Mare Serum Gonadotrophin) 3 days before the eggs were
required to increase the number of stage 6 mature oocytes
and 2 days later, were injected with 500 units Chorulon
(Chorionic Gonadotrophin) to induce ovulation. Frogs were
placed in individual laying tanks at 18–21°C in 2 l 1× MMR
egg laying buffer, prepared from a 10× stock (1 M NaCl,
20 mM KCl, 10 mM MgCl2, 20 mM CaCl2,1 mM EDTA,
50 mM HEPES NaOH, pH 7.8). The following morning,
eggs were collected and rinsed in 1× MMR to remove any
non-egg debris. Washed eggs were dejellied in 2% w/v
cysteine (pH 7.8), washed in XBE2 (1× XB salts, 1.71% w:v
sucrose, 5 mM K-EGTA, 10 mM HEPES KOH, pH 7.7; 10×
XB salts: 2 M KCl, 40 mM MgCl2, 2 mM CaCl2) and then
into XBE2 containing 10 µg ml−1 leupeptin, pepstatin and
aprotinin. Dejellied and washed eggs were centrifuged in
14 ml tubes, containing 1 ml XBE2 plus protease inhibitors
containing 100 µg ml−1 cytochalasin D, at 1400g in a swing-
ing bucket rotor for 1 min at 16°C to pack the eggs, after
which excess buffer and dead eggs were removed. Packed
eggs were crushed by centrifugation at 16 000g in a swinging
bucket rotor for 10 min at 16°C. The dirty brown cytoplasmic
layer was collected using a 20 G needle and a 1 ml syringe via
side puncture. From this point onwards, the extract was kept
on ice. The crude extract was supplemented with cytochala-
sin D, leupeptin, pepstatin and aprotinin all to a final
concentration of 10 µg ml−1, 1 : 80 dilution of energy regen-
erator (1 M phosphocreatine disodium salt, 600 µg ml−1
creatine phosphokinase in 10 mM HEPES KOH, pH 7.6)
and 15% v:v LFB1/50 (10% w:v sucrose, 50 mM KCl, 2 mM
MgCl2, 1 mM EGTA, 2 mM DTT, 20 mM K2HPO4/KH2PO4
pH 8.0, 40 mM HEPES KOH, pH 8.0). The extract was clari-
fied by centrifugation at 84 000g in a pre-cooled SW55
swinging bucket rotor at 4°C for 20 min. The golden cyto-
plasmic layer was recovered, supplemented with glycerol to
2% v/v and frozen in aliquots in liquid nitrogen and stored
at −80°C until required.
Sperm was recovered from testes isolated from male frogs
post-mortem following a lethal dose of anaesthetic (0.2% w:v
Tricaine mesylate MS222, approx. 0.5% w:v NaHCO3 to pH
7.5). Isolated testes were washed carefully to avoid bursting
in EB (50 mM KCl, 5 mM MgCl2, 2 mM dithiothreitol or
β-mercaptoethanol, 50 mM HEPES KOH, pH 7.6), prior to
being finely chopped with a clean razor blade in fresh EB.
Recovered lysate was filtered through a 25 µm nylon mem-
brane to remove particulate matter. Filtered sperm was
centrifuged at 2000g at 4°C for 5 min; selective resuspension
of the sperm pellet allowed separation of the sperm from con-
taminating erythrocytes; the resuspended sperm was respun
and the pellet resuspended in 0.5 ml SuNaSp (0.25 M sucrose,
75 mM NaCl, 0.5 mM spermidine, 0.15 mM spermine, 15 mMHEPES KOH, pH 7.6) per testis. The sperm was demembra-
nated with the addition of 25 µl per testis lysolecithin
(5 mg ml−1, in H2O) for 10 min at room temperature. Demem-
branated sperm were respun and resuspended in SuNaSp
plus 3% w/v BSA to quench the demembranation reaction.
Quenched sperm were respun and resuspended in 100 µl
EB plus 30% glycerol per testis, counted using a haemo-
cytometer and stored at −80°C.
Extracts were supplemented with 250 µg ml−1 cyclohexi-
mide, 25 mM phosphocreatine and 15 µg ml−1 creatine
phosphokinase and incubated with 0.3 mM CaCl2 for 15 min
to trigger release from metaphase arrest. For DNA synthesis
reactions, demembranated Xenopus sperm nuclei were incu-
bated at 3–10 ng DNA µl−1 in extract. DNA synthesis was
assayed by measuring incorporation of [α-32P] dATP into
acid-insoluble material followed by scintillation counting, as
described [24,64]. Extract was supplemented with 50 nCi µl−1
[α-32P] dATP from a high activity 10 mCi ml−1 stock. At the
appropriate times, 10 µl aliquots was stopped by the addition
of 160 µl Stop-C (0.5% w:v SDS, 5 mM EGTA, 20 mM Tris
HCl, pH 7.5) plus freshly added 0.2 mg ml Proteinase K
(from stock of 20 mg ml−1 proteinase K, 50% v:v glycerol,
10 mM Tris–HCl, pH 7.5) and were incubated at 37°C for
30 min. Samples are precipitated at 4°C for 30 min by the
addition of 4 ml 10% TCA (10% w:v TCA, 2% w:v Na4P2O7-
·10H2O). Forty microlitres (1% of 4 ml) of the total reaction
were spotted on a paper disc. Insoluble material was recovered
from solution by filtration through a glass fibre filter mounted
on a vacuum manifold. The glass fibre filters were twice
washed in 5% TCA (5% w:v TCA, 0.5% w:v Na4P2O7.10H2O),
once in 100% ethanol and then air dried. The paper and glass
fibre filters were then quantified by scintillation counting. Pre-
cipitatedmaterial was expressed as a percentage of total counts
(%TC) fromwhichDNA replication (ng µl−1) was calculated by
multiplying by a factor of 0.654. The extent of nuclear for-
mation was followed under the light microscope (phase
contrast). All incubations were carried out at 23°C.
Licensing factor extract (LFE) was prepared as described
[65]. The initial steps for preparingmetaphase extractswere fol-
lowed. Before the final spin, the extract was activated with
0.3 mM CaCl2 for 15 min then diluted fivefold with ‘Licensing
Factor Buffer’ (LFB1: 40 mM HEPES KOH pH 8.0, 20 mM
K2HPO4/KH2PO4 pH 8.0, 2 mM MgCl2, 1 mM EGTA, 2 mM
DTT, 10% (w/v) sucrose and 1 µg ml−1 each of leupeptin, pep-
statin and aprotinin) supplemented with 50 mM KCl (i.e.
LFB1/50) and spun to remove membrane components at
84 000g in a pre-cooled SW55 rotor swinging bucket rotor at
4°C for 40 min. The clarified supernatant was frozen, in
aliquots, in liquid nitrogen and stored at −80°C till required.
Membrane-free extract (MFE) used for TopBP1 immuno-
precipitation experiments was prepared as per LFE, above,
but was spun at 186 000g in a pre-cooled TLA-100 fixed
angle rotor at 4°C for 20 min and recovered supernatant
was used immediately.
Immunodepleted extract was prepared as described [65].
Briefly, rProtein-A agarose beads (Cytiva LifeSciences), prein-
cubated with 2 volumes of serum, were twice incubated with
interphase whole egg extract at a ratio of 1 volume extract
plus 0.7 volume beads. Twice depleted extract, recovered
from the beads, was frozen in aliquots in liquid nitrogen
and stored at −80°C.
Immunoprecipitations using affinity purified anti-








































performed following the manufacturer’s instructions
(ThermoFisher Scientific).
4.3.3. Chromatin isolation
All chromatin isolations fromXenopus egg extractswere under-
taken in low-adhesive Eppendorf tubes, as described [24,64].
Briefly, reactions were stopped by the addition of 400 µl of
ice-cold NIBTX (50 mM KCl, 50 mM HEPES KOH pH 7.6,
5 mM MgCl2, 2 mM DDT, 0.5 mM spermidine 3HCl,
0.15 mM spermine 4HCl, 0.1% Triton X-100). This was under-
layered with 100 µl 15% sucrose in NIBTX. The tubes were
spun at 6000g for 5 min at 4°C in a swinging bucket rotor.
The buffer above the sucrose cushionwas removed and the sur-
face of the cushionwashedwith 200 µlNIBTX before removing
the cushion down to approximately 15 µl. The tubes were then
spun at 13 000g for 2 min in a fixed angle rotor to focus the
chromatin pellet and following this, all the buffer was
removed. The chromatin pellet was then resuspended in load-
ing buffer and was subjected to immunoblotting by standard
techniques using 4–12% Bis–Tris gradient SDS–PAGE gel
(Invitrogen) with the exception of figure 7a for which a 3–8%
Tris–Acetate gel (Invitrogen) was used.
For nuclear transfer experiments, 90 µl interphase extract
supplemented with appropriate inhibitors was incubated
with 26 ng µl−1 of sperm nuclei for 1 h. Extract was diluted
with 1 ml of NIB50 buffer (50 mM KCl, 50 mM HEPES
KOH pH 7.6, 5 mM MgCl2, 2 mM DDT, 0.5 mM spermidine
3HCl, 0.15 mM spermine 4HCl) without Triton X-100, under-
laid with 100 µl NIB50 containing 15% sucrose, and 5 µl
NIB50 containing 30% glycerol, and spun at 2100g, 5 min at
4°C in a swinging bucket rotor bench centrifuge. The sucrose
cushion was washed with 200 µl NIB50, the buffer was
removed leaving approximately 15 µl. Nuclei were gently
resuspended and frozen in liquid nitrogen.
For the geminin chromatin transfer assay [66], 80 µl of
extract were activated and incubated for 5 min with 120 nM
recombinant gemininDEL, 20 ng µl−1 of demembranated
sperm nuclei were added to the extract and incubated for
12 min. Chromatin was isolated by diluting the reaction with
1 ml of NIB50, underlaid with 100 µl of NIB50 containing
15% sucrose, underlaid with 5 µl of NIB50 containing 30% gly-
cerol and spun at 6000g, 5 min at 4°C in a swinging bucket rotor
bench centrifuge, all in the absence of Triton X-100. The buffer
above the sucrose cushionwaswashedwith 200 µl NIB50with-
out Triton and the buffer was removed leaving approximately
15 µl sample. Chromatin was gently resuspended by inversion
and frozen in aliquots in liquid nitrogen.
4.3.4. Immunoblotting
Samples were prepared in 6× Laemmli sample buffer heated at
99°C for 4 min and separated on 4–12% Bis–Tris NuPage gels
(Invitrogen) in 1× MOPS running buffer (Invitrogen) or 3–8%
Tris–Acetate gels (Invitrogen) in Tris–Acetate running buffer
(Invitrogen). Proteins were transferred onto nitrocellulose
membrane (Cytiva LifeSciences) and images captured using
an Odyssey SLX LiCor Scanner (Licor Bioscience) when
using fluorescently labelled secondary antibodies or trans-
ferred onto PVDF (Cytiva LifeSciences) when detected using
enhanced chemiluminescence detection (Pierce SuperSignal
West Pico Chemiluminescent Substrate 34087; ThermoFisher
Scientific) and images captured using an ImageQuantLAS4000 (Cytiva LifeSciences) CCD. Quantification of MTBP
was carried out using pre-diluted Bovine Gamma Globulin
protein assay standards (Pierce 23213; ThermoFisher Scientific)
and analysed using Image Studio Lite LICOR software.
For protein visualization, gels were stained with either
SYPRO Ruby (ThermoFisher Scientific) and de-stained with
10% ethanol and 7% acetic acid in H2O or with Coomassie R-
250 andde-stainedwith 40%ethanol and10%acetic acid inH2O.
4.3.5. Mass spectrometry
Immunoprecipitated samples for mass spectrometry were run
onNuPage gels and stainedwith SimplyBlue SafeStain (Invitro-
gen). Bands at the size of Treslin and MTBP were cut from gels
and reduced with dithiothreitol, alkylated with iodoacetamide
and in-gel digestedwith trypsin. The extractedpeptide solutions
were analysedusingnanoLC-MS/MSonanLTQOrbitrapVelos
(ThermoFisher Scientific).
4.3.6. Gel filtration and glycerol gradients
For gel filtration, 100 µl of a 3% PEG precipitate resuspended
in LFB1/50 to a final volume of twice that of undiluted
extract was applied to an Agilent BIO SEC-5 column (500 Å
4.6 × 300 mm, range 15–5000 kDa) equilibrated in LFB1/50.
The column was run at a flow rate of 150 µl min−1 on an Ulti-
Mate 3000 chromatography system (ThermoFisher Scientific)
at 4°C and 75 µl fractions were collected. For sucrose gradient
centrifugation, 440 µl of a 3% PEG precipitate resuspended in
LFB1/50 to a final volume of twice that of undiluted extract
was applied to an 11 ml 5–40% sucrose gradient prepared
in LFB1/50. Gradients were spun at 40 000 rpm (approx.
111 000g) for 20 h in a SW41Ti swinging bucket rotor in a
Beckman Optima ultracentrifuge. Four hundred and forty
microlitre fractions were collected.
Molecular masses were calculated according to Siegel &
Monty [25] using the values: thyroglobulin tetramer
(1338 kDa, 107 Å), thyroglobulin dimer (669 kDa, 85 Å, 19.5
S), apoferritin (443 kDa, 67 Å, 17.6 S), β-amylase (200 kDa,
54 Å, 8.9 S), BSA (66 kDa, 35.5 Å, 4.3 S), carbonic anhydrase
(29 kDa, 24.3 Å, 3.2 S) (Sigma-Aldrich MWGF1000).
4.3.7. Partial purification of Treslin–MTBP
PEG precipitation was carried out as described [65]. Briefly, to
one volume of LFE, the required volume of 50% v:v of PEG
6000 in H2O was added, mixed well and incubated for
30 min on ice-water. The samples were spun at 20 000g,
30 min at 4°C in a fixed angle rotor. The supernatant was
removed and the pellet resuspended in the required
amount of LFB1/50 (50 mM KCl, 20 mM K2HPO4/KH2PO4
pH 8.0, 40 mM HEPES KOH pH 8.0, 2 mM MgCl2, 1 mM
EGTA, 2 mM dithiothreitol, 10% (w:v) sucrose).
SP and ANX HiTrap 1 ml columns (Cytiva LifeSciences)
were washed with 5 column volumes of H2O, 5 column
volumes of LFB1/50, 5 column volumes of LFB1 containing
1 M KCl and 10 column volumes of LFB1/50. Samples
were spun at 21 910g for 20 min at 4°C in a fixed angle
rotor in a benchtop centrifuge prior to column loading. Col-
umns were connected to an AKTApurifier UPC10 system
(Cytiva LifeSciences) or to an UltiMate3000 chromatography
system (ThermoFisher Scientific). When the OD280 was







































were eluted through a gradient from 50 to 750 mM KCl in
14 × 1 ml fractions at a flow rate of 1 ml min−1.
4.3.8. Quantification and statistical analysis
Statistical data for individual experiments are presented in
the appropriate figure legends. In all cases, ‘n’ is the
number of independent experimental repeats from which
the mean ± s.e.m. has been calculated.
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